Lithostat
NDC 0178-0500, acetohydroxamic acid, tablet, from Mission Pharmacal Company.
- Product NDC
- 0178-0500
- Status
- Listed
- Labeler
- Mission Pharmacal Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018749
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0178-0500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETOHYDROXAMIC ACID250 mg/1
Pharmacologic classes
Urease Inhibitor [EPC]; Urease Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0178-0500-01 | 00178050001 | 100 TABLET in 1 BOTTLE (0178-0500-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6660b616-a82d-9109-19ce-2bdf9747aceaNADAC price for package 00178050001
GET /v1/drugs/nadac/00178050001
Use it
Look up 0178-0500 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0178-0500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0178-0500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.